CTSB and Hepatitis: This last observation could explain why in the α-GalCer model, where TNF is involved in α-GalCer-induced upregulation of FasL on NKT cells, but hepatocyte damage depends mainly on FasL (65), CTSB inhibition did not protect against α-GalCer mediated hepatitis.